A Population-based Analysis of Esophageal and Gastric Cardia Adenocarcinomas in Ontario, Canada: Incidence, Risk Factors, and Regional Variation

Overview

Journal J Gastrointest Surg

Specialty Gastroenterology

Date 2011 Mar 17

PMID 21409602

Citations 8

Authors

Jill Tinmouth

Josh Green

Yoo-Joung Ko

Ying Liu

Lawrence Paszat

Rinku Sutradhar

Linda Rabeneck

David Urbach

Affiliations

Soon will be listed here.

Abstract

Introduction: In Western countries, the incidence of esophageal adenocarcinoma (EA) and gastric cardia adenocarcinoma (GCA) is increasing. This population-based study describes the incidence of, associated patient risk factors for, and regional variation in EA/GCA in Ontario, Canada.

Methods: All adults with a new diagnosis of EA or GCA between 1972 and 2005 in Ontario were identified. Adjusted annual incidence rates were calculated, and multivariate models were used to identify patient risk factors. Maps were created to explore regional variation.

Results: Over the study period, 8,245 persons were diagnosed with EA/CGA; incidence increased from 1.01 to 3.9 per 100,000. Age (>65 vs. <50 years; rate ratio (RR), 3.4; 95% confidence interval (CI), 2.8-4.1) and comorbidity (highest vs. lowest, RR, 3.5; 95% CI, 2.9-4.2) were most strongly associated with the development of EA/GCA. We found considerable regional variation in the rates of EA/GCA (North West vs. Central region, RR, 6.5; 95% CI, 4.4-9.6). Maps suggested ethnicity may explain some regional variation, and that the current allocation of designated surgical treatment centers for EA/CGA may be suboptimal.

Conclusions: The incidence of EA/GCA is rising dramatically in Ontario. Further investigation of observed regional variation is warranted, particularly for the allocation of cancer health resources.

Citing Articles

Impact of Residing in Below Median Household Income Districts on Outcomes in Patients with Advanced Barrett's Esophagus.

Li S, Fujiyoshi Y, Jugnundan S, May G, Marcon N, Mosko J J Can Assoc Gastroenterol. 2023; 6(4):137-144.

PMID: 37538188 PMC: 10395662. DOI: 10.1093/jcag/gwad018.

Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO): protocol for a multicentre clinical and pathological database including 25 000 patients.

Gupta V, Levy J, Allen-Ayodabo C, Amirazodi E, Davis L, Li Q BMJ Open. 2020; 10(5):e032729.

PMID: 32474423 PMC: 7264637. DOI: 10.1136/bmjopen-2019-032729.

Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study.

Cattelan L, Ghazawi F, Le M, Lagace F, Savin E, Zubarev A Cancer Med. 2019; 9(1):401-417.

PMID: 31715645 PMC: 6943153. DOI: 10.1002/cam4.2700.

Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.

Thein H, Jembere N, Thavorn K, Chan K, Coyte P, de Oliveira C BMC Cancer. 2018; 18(1):694.

PMID: 29945563 PMC: 6020438. DOI: 10.1186/s12885-018-4620-2.

Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.

Thein H, Anyiwe K, Jembere N, Yu B, De P, Earle C PLoS One. 2017; 12(10):e0186350.

PMID: 29020052 PMC: 5636169. DOI: 10.1371/journal.pone.0186350.

References

Sundaresan S, Langer B, Oliver T, Schwartz F, Brouwers M, Stern H . Standards for thoracic surgical oncology in a single-payer healthcare system. Ann Thorac Surg. 2007; 84(2):693-701. DOI: 10.1016/j.athoracsur.2007.03.069. View

Botterweck A, Schouten L, Volovics A, Dorant E, van den Brandt P . Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000; 29(4):645-54. DOI: 10.1093/ije/29.4.645. View

Pohl H, Welch H . The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005; 97(2):142-6. DOI: 10.1093/jnci/dji024. View

Weiner J, Starfield B, Steinwachs D, Mumford L . Development and application of a population-oriented measure of ambulatory care case-mix. Med Care. 1991; 29(5):452-72. DOI: 10.1097/00005650-199105000-00006. View

Reid R, Roos N, MacWilliam L, Frohlich N, Black C . Assessing population health care need using a claims-based ACG morbidity measure: a validation analysis in the Province of Manitoba. Health Serv Res. 2002; 37(5):1345-64. PMC: 1464032. DOI: 10.1111/1475-6773.01029. View

Powell J, McConkey C . Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer. 1990; 62(3):440-3. PMC: 1971432. DOI: 10.1038/bjc.1990.314. View

Steffen A, Schulze M, Pischon T, Dietrich T, Molina E, Chirlaque M . Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2009; 18(7):2079-89. DOI: 10.1158/1055-9965.EPI-09-0265. View

Lagergren J, Bergstrom R, Lindgren A, Nyren O . Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999; 340(11):825-31. DOI: 10.1056/NEJM199903183401101. View

Sihvo E, Salminen J, Ramo O, Salo J . The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma?. Scand J Gastroenterol. 2000; 35(10):1082-6. DOI: 10.1080/003655200451216. View

10.

Lord R, Law M, Ward R, Giles G, Thomas R, Thursfield V . Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol. 1998; 13(4):356-62. DOI: 10.1111/j.1440-1746.1998.tb00646.x. View

11.

Blot W, Devesa S, Kneller R, Fraumeni Jr J . Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991; 265(10):1287-9. View

12.

Kort E, Sevensma E, Fitzgerald T . Trends in esophageal cancer and body mass index by race and gender in the state of Michigan. BMC Gastroenterol. 2009; 9:47. PMC: 2708181. DOI: 10.1186/1471-230X-9-47. View

13.

Singh S, Paszat L, Li C, He J, Vinden C, Rabeneck L . Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study. CMAJ. 2004; 171(5):461-5. PMC: 514642. DOI: 10.1503/cmaj.1031921. View

14.

Alter D, Naylor C, Austin P, Tu J . Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med. 1999; 341(18):1359-67. DOI: 10.1056/NEJM199910283411806. View

15.

Hongo M, Nagasaki Y, Shoji T . Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009; 24(5):729-35. DOI: 10.1111/j.1440-1746.2009.05824.x. View

16.

Starfield B, Weiner J, Mumford L, Steinwachs D . Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res. 1991; 26(1):53-74. PMC: 1069810. View

17.

Deyo R, Cherkin D, Ciol M . Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45(6):613-9. DOI: 10.1016/0895-4356(92)90133-8. View

18.

Bashash M, Shah A, Hislop G, Brooks-Wilson A, Le N, Bajdik C . Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. Can J Gastroenterol. 2008; 22(2):143-8. PMC: 2659133. DOI: 10.1155/2008/645107. View

19.

Baquet C, Commiskey P, Mack K, Meltzer S, Mishra S . Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc. 2005; 97(11):1471-8. PMC: 2594901. View

20.

Parfitt J, Miladinovic Z, Driman D . Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada -- an epidemiological study from 1964-2002. Can J Gastroenterol. 2006; 20(4):271-6. PMC: 2659904. DOI: 10.1155/2006/175751. View